Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Long-Acting Injection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03422172
What this trial is testing

A Safety, Tolerability, Acceptability, and Pharmacokinetic (PK) Study of Cabotegravir (CAB) in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Chinese Men

Who this might be right for
HIV Infections
ViiV Healthcare 48
Not applicableEnrolling By InvitationNCT06488846
What this trial is testing

Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home

Who this might be right for
HIV Infections
University of California, San Francisco 1,000
Not applicableLooking for participantsNCT07579754
What this trial is testing

BetterInfo on Women's PrEP Choices and Outcomes in Malawi

Who this might be right for
Long-acting Injectable Cabotegravir for PrEPOral Pre-Exposure Prophylaxis (PrEP)
Johns Hopkins Bloomberg School of Public Health 384
Post-approval studies (Phase 4)UnknownNCT04910711
What this trial is testing

Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIV

Who this might be right for
Human Immunodeficiency VirusContraceptionART
Botswana Harvard AIDS Institute Partnership 140
Testing effectiveness (Phase 2)Study completedNCT02088177
What this trial is testing

Study of Long-Acting Injectable Naltrexone to Treat Cannabis Dependence

Who this might be right for
Cannabis Dependence
New York State Psychiatric Institute 12
Early research (Phase 1)Study completedNCT04709224
What this trial is testing

Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Intra-Cellular Therapies, Inc. 37
Early research (Phase 1)Study completedNCT06627413
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Schizophrenia or Schizoaffective
Intra-Cellular Therapies, Inc. 52
Early research (Phase 1)Study completedNCT01031589
What this trial is testing

TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 19
Early research (Phase 1)Study completedNCT02609126
What this trial is testing

Safety Study of a Long-Acting Injectable Steroid to Treat Knee Osteoarthritis

Who this might be right for
Osteoarthritis, Knee
Eupraxia Pharmaceuticals Inc. 32
Testing effectiveness (Phase 2)Study completedNCT04030143
What this trial is testing

A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder

Who this might be right for
SchizophreniaBipolar I Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 266
Testing effectiveness (Phase 2)Ended earlyNCT04433546
What this trial is testing

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).

Who this might be right for
Acute Respiratory Distress SyndromeCoronavirusHypoxic Respiratory Failure+15 more
PhaseBio Pharmaceuticals Inc. 54
Not applicableStudy completedNCT05833542
What this trial is testing

Assessing Perceptions and Preferences Around Long-acting Injectables (APPLI)

Who this might be right for
Hiv
City University of New York 243
Large-scale testing (Phase 3)Study completedNCT01281527
What this trial is testing

Paliperidone Palmitate Flexible Dosing in Schizophrenia

Who this might be right for
Schizophrenia
Janssen-Cilag International NV 1,044
Post-approval studies (Phase 4)Study completedNCT00369239
What this trial is testing

Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis

Who this might be right for
SchizophreniaPsychotic DisordersSchizoaffective Disorder
Janssen Pharmaceutica N.V., Belgium 303
Early research (Phase 1)Looking for participantsNCT07061288
What this trial is testing

Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

Who this might be right for
Schizophrenia
Bristol-Myers Squibb 131
Not applicableUnknownNCT03390712
What this trial is testing

Mirror-image Study of Paliperidone Palmitate and Risperidone Long-acting Injection

Who this might be right for
Schizophrenia Spectrum and Other Psychotic Disorders
Réseau de Santé Vitalité Health Network 328
Large-scale testing (Phase 3)Study completedNCT02431702
What this trial is testing

Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen Scientific Affairs, LLC 337
Large-scale testing (Phase 3)Not Yet RecruitingNCT06273943
What this trial is testing

Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.

Who this might be right for
Prevention
ANRS, Emerging Infectious Diseases 322
Early research (Phase 1)Study completedNCT05953740
What this trial is testing

MK-5720 in Participants With Schizophrenia (MK-5720-001)

Who this might be right for
Schizophrenia
Merck Sharp & Dohme LLC 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07816250
What this trial is testing

A Phase 2b Study Evaluating VH4011499 Capsid Inhibitor Long-Acting Injectable Plus Cabotegravir in Treatment Naïve Adults (CINERGY)

Who this might be right for
HIV Infections
ViiV Healthcare 200
Next Page